Hospital

The implementation of multi-gene panel testing may be a necessary part of the standard of care for all colorectal cancer patients.

Pharmacy Times® interviewed the CEO of US Pharmacopeia (USP) Ronald Piervincenzi, PhD, to discuss USP’s history, the role of the pharmacist both in that history and in USP’s work today, and USP’s outlook on the future of pharmacy.

Seeing the vital role of pharmacists during the pandemic has solidified many students' desire to join the profession.

Nasir Iqbal, PharmD, Rphl, the director of pharmacy at NYC Health + Hospitals/Lincoln, discusses the COVID-19 vaccine rollout at the Lincoln Medical Center in the Bronx.

Pharmacy practice is becoming more integrated into the health system and features more collaborative practice opportunities.

Further integration with care teams and using data to demonstrate the value of pharmacists will be essential to maintaining the momentum created by the COVID-19 pandemic.

Ed Zacharias, a managing partner of the Boston office at McDermott Will & Emery and a partner in the health industry advisory group, discusses the intersection of telemedicine and cybersecurity, specifically in relation to ransomware attacks.

Approximately 450,000 cases of Clostridioides difficile infection occur each year in the United States and approximately 25% of patients treated for an initial episode will experience recurrence.

The researchers analyzed health outcomes in 283 heart attack survivors between 18 and 61 years of age, with an average age of 51 years.

In an interview with Pharmacy Times®, Melissa Santibañez, PharmD, BCCCP, assistant professor at Nova Southeastern University College of Pharmacy, Fort Lauderdale, Florida; and critical care clinical pharmacist at Memorial Regional Hospital, Hollywood, Florida, discusses the value of a pharmacist on a patient care team.

Research is ongoing in younger children between the ages of 6 months and 11 years of age, with first doses administered in March 2021.

Rosemarie Leighton, RPh, director of pharmacy, NYC Health + Hospitals/Jacobi, discussed the coordination of COVID-19 vaccinations at the Jacobi Medical Center in the Bronx.

The study is one of the first to show an association between COVID-19 vaccination and fewer asymptomatic infections, according to the authors.

HIV is currently not curable but can be controlled with effective treatment options to allow patients to live a healthy life with better quality.

Tivozanib was the first therapy approved by the FDA for adult patients with relapsed or refractory advanced renal cell carcinoma following 2 or more prior systemic therapies.

The researchers said that the findings should renew efforts to assure flu vaccination is a routine part of quality cardiovascular care.

These findings also suggest that the efficacy of radiotherapy can be improved with drugs that block the PDGFRb protein.

Although it is currently used off-label for many neuroinflammatory and neurodegenerative disorders, intravenous immunoglobulin is showing promise for a growing number of neurological diseases.

The percentage of patients who received an opioid among all ED visits during the 2018 shortage fell significantly from 11.5% pre-shortage to 8.5% during, and did not return to baseline once the shortage had ended.

The study authors noted that 340B participating hospitals may be better positioned to create and administer programs that support patients who are uninsured or underinsured, and those who may have job, transportation, and other social insecurities.

Suzanne Soliman, PharmD, BCMAS, and Sally Arif, PharmD, BCPS, BCCP, discussed the important role of working mothers in the pharmacy field.

The researchers obtained genomic data from more than 2000 pediatric patients with leukemia to identify associated gene variants.

The companies have also submitted an application to expand the current EUA for the COVID-19 vaccine to include individuals 12 to 15 years of age.

The new study evaluated data from 5000 patients with EBC and 3496 with ABC to determine associations between BMI and survival rates across both stages.

Although prolonged COVID-19 infections are rare, even in children or young adults with compromised immunity, it could have public health implications.

The authors of the study suggest that any patient with HZ should be tested for COVID-19, even if the individual has mild symptoms or no history of upper respiratory symptoms.

This indication has received accelerated approval based on tumor response rate and durability of response, though the results of confirmatory trials may change the approval status.

The study is most comprehensive analysis to date of changes in hospital mortality throughout the pandemic, reviewing data on more than 20,000 patients admitted to hospitals for COVID-19 over 9 months, according to the Institute for Health Metrics and Evaluation at the University of Washington.